Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs

被引:48
作者
Rasolofonjatovo, Evelia [1 ]
Provot, Olivier [1 ]
Hamze, Abdallah [1 ]
Rodrigo, Jordi [1 ]
Bignon, Jerome [2 ]
Wdzieczak-Bakala, Joanna [2 ]
Lenoir, Christine [2 ]
Desravines, Deborah [2 ]
Dubois, Joelle [2 ]
Brion, Jean-Daniel [1 ]
Alami, Mouad [1 ]
机构
[1] Univ Paris Sud, Fac Pharm, CNRS, Chim Therapeut Lab,LabEx LERMIT,BioCIS UMR 8076, F-92296 Chatenay Malabry, France
[2] CNRS, Inst Chim Subst Nat, UPR 2301, F-91198 Gif Sur Yvette, France
关键词
Benzoxepin; Combretastatin; isoCA-4; Tubulin; Cytotoxicity; Apoptosis; Cancer; COMBRETASTATIN A4 PHOSPHATE; ARYL HALIDES SYNTHESIS; ANTINEOPLASTIC AGENTS; BIOLOGICAL EVALUATION; TUBULIN POLYMERIZATION; REGIOSELECTIVE ACCESS; CATALYZED REACTION; ANTITUMOR-ACTIVITY; N-TOSYLHYDRAZONES; ARYLALKYNES;
D O I
10.1016/j.ejmech.2012.12.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel benzoxepins 6 was designed and prepared as rigid-isoCA-4 analogs according to a convergent strategy using the coupling of N-tosylhydrazones with aryl iodides under palladium catalysis. The most potent compound 6b, having the greatest resemblance to CA-4 and isoCA-4 displayed antiproliferative activity at nanomolar concentrations against various cancer cell lines and inhibited tubulin assembly at a micromolar range. In addition, benzoxepin 6b led to the arrest of HCT116, K562, H1299 and MDA-MB231 cancer cell lines in the G(2)/M phase of the cell cycle, and strongly induced apoptosis at low concentrations. Docking studies demonstrated that benzoxepin 6b adopt an orientation similar to that of isoCA-4 at the colchicine binding site on beta-tubulin. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:28 / 39
页数:12
相关论文
共 74 条
[1]  
Alami M, 2002, ANGEW CHEM INT EDIT, V41, P1578, DOI 10.1002/1521-3773(20020503)41:9<1578::AID-ANIE1578>3.0.CO
[2]  
2-C
[3]   AN EFFICIENT PALLADIUM-CATALYZED REACTION OF VINYL AND ARYL HALIDES OR TRIFLATES WITH TERMINAL ALKYNES [J].
ALAMI, M ;
FERRI, F ;
LINSTRUMELLE, G .
TETRAHEDRON LETTERS, 1993, 34 (40) :6403-6406
[4]   The selective reaction of aryl halides with KOH: Synthesis of phenols, aromatic ethers, and benzofurans [J].
Anderson, Kevin W. ;
Ikawa, Takashi ;
Tundel, Rachel E. ;
Buchwald, Stephen L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (33) :10694-10695
[5]   In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes [J].
Aprile, Silvio ;
Del Grosso, Erika ;
Tron, Gian Cesare ;
Grosa, Giorgio .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) :2252-2261
[6]   Synthesis and Structure-Activity Relationships of Constrained Heterocyclic Analogues of Combretastatin A4 [J].
Arthuis, Martin ;
Pontikis, Renee ;
Chabot, Guy G. ;
Seguin, Johanne ;
Quentin, Lionel ;
Bourg, Stephane ;
Morin-Allory, Luc ;
Florent, Jean-Claude .
CHEMMEDCHEM, 2011, 6 (09) :1693-1705
[7]   N-tosylhydrazones as reagents for cross-coupling reactions:: A route to polysubstituted olefins [J].
Barluenga, José ;
Moriel, Patricia ;
Valdes, Carlos ;
Aznar, Fernando .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (29) :5587-5590
[8]   Tosylhydrazones: New Uses for Classic Reagents in Palladium-Catalyzed Cross-Coupling and Metal-Free Reactions [J].
Barluenga, Jose ;
Valdes, Carlos .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (33) :7486-7500
[9]   Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators [J].
Barrett, Irene ;
Meegan, Mary J. ;
Hughes, Rosario B. ;
Carr, Miriam ;
Knox, Andrew J. S. ;
Artemenko, Natalia ;
Golfis, Georgia ;
Zisterer, Daniela M. ;
Lloyd, David G. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (21) :9554-9573
[10]   Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects [J].
Barrett, Irene ;
Carr, Miriam ;
O'Boyle, Niamh ;
Greene, Lisa M. ;
Knox, Andrew J. S. ;
Lloyd, David G. ;
Zisterer, Daniela M. ;
Meegan, Mary J. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2010, 25 (02) :180-194